Showing 1 posts of 1 posts found.
French firm Valneva has announced that its Lyme disease vaccine, known at this stage only by VLA15, has been fast-tracked …
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection
Coriolis Pharma appoints Teun van der Heide as CEO
NEC joins €6.5m European project using AI for pandemic vaccine design